How to buy OptimizeRx Corporation stock

OptimizeRx Corporation is a health information services business based in the US. OptimizeRx Corporation shares (OPRX) are listed on the NASDAQ and all prices are listed in US Dollars. OptimizeRx Corporation employs 71 staff and has a trailing 12-month revenue of around 0.00.

OptimizeRx Corporation share price

Use our graph to track the performance of OPRX stocks over time.

OptimizeRx Corporation shares at a glance

• Key figures

Information last updated 2021-04-22.

52-week range	$8.66 - $63.98
50-day moving average	$48.80
200-day moving average	$37.73
Wall St. target price	$72.75
PE ratio	247.0732
Dividend yield	N/A (0%)
Earnings per share (TTM)	$0.04

Buy OptimizeRx Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy OptimizeRx Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of OptimizeRx Corporation by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is OptimizeRx Corporation under- or over-valued?

Valuing OptimizeRx Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of OptimizeRx Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

OptimizeRx Corporation's P/E ratio

OptimizeRx Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 247x. In other words, OptimizeRx Corporation shares trade at around 247x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

OptimizeRx Corporation's PEG ratio

OptimizeRx Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.236. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into OptimizeRx Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

OptimizeRx Corporation's EBITDA

OptimizeRx Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $646,895.

The EBITDA is a measure of a OptimizeRx Corporation's overall financial performance and is widely used to measure a its profitability.

OptimizeRx Corporation financials

Revenue TTM	$43.3 million
Gross profit TTM	$24.1 million
Return on assets TTM	-1.41%
Return on equity TTM	-4.66%
Profit margin	-5.1%
Book value	$3.28
Market capitalisation	$815.6 million

TTM: trailing 12 months

Shorting OptimizeRx Corporation shares

There are currently 1.0 million OptimizeRx Corporation shares held short by investors – that's known as OptimizeRx Corporation's "short interest". This figure is 14.1% up from 887,062 last month.

There are a few different ways that this level of interest in shorting OptimizeRx Corporation shares can be evaluated.

OptimizeRx Corporation's "short interest ratio" (SIR)

OptimizeRx Corporation's "short interest ratio" (SIR) is the quantity of OptimizeRx Corporation shares currently shorted divided by the average quantity of OptimizeRx Corporation shares traded daily (recently around 338433.44481605). OptimizeRx Corporation's SIR currently stands at 2.99. In other words for every 100,000 OptimizeRx Corporation shares traded daily on the market, roughly 2990 shares are currently held short.

However OptimizeRx Corporation's short interest can also be evaluated against the total number of OptimizeRx Corporation shares, or, against the total number of tradable OptimizeRx Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case OptimizeRx Corporation's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 OptimizeRx Corporation shares in existence, roughly 60 shares are currently held short) or 0.0623% of the tradable shares (for every 100,000 tradable OptimizeRx Corporation shares, roughly 62 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against OptimizeRx Corporation.

Find out more about how you can short OptimizeRx Corporation stock.

OptimizeRx Corporation share dividends

We're not expecting OptimizeRx Corporation to pay a dividend over the next 12 months.

Have OptimizeRx Corporation's shares ever split?

OptimizeRx Corporation's shares were split on a 1:3 basis on 13 May 2018. So if you had owned 3 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your OptimizeRx Corporation shares – just the quantity. However, indirectly, the new 200% higher share price could have impacted the market appetite for OptimizeRx Corporation shares which in turn could have impacted OptimizeRx Corporation's share price.

OptimizeRx Corporation share price volatility

Over the last 12 months, OptimizeRx Corporation's shares have ranged in value from as little as $8.66 up to $63.98. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while OptimizeRx Corporation's is 0.6498. This would suggest that OptimizeRx Corporation's shares are less volatile than average (for this exchange).

OptimizeRx Corporation overview

OptimizeRx Corporation operates as a digital health company that provides communications solutions for life science companies, physicians, and patients. Its products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, therapeutic support messages, and unbranded messages. The company also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing new eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, it operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform that allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, the company offers patient programs with treatment and affordability information, lifestyle and condition trackers, Internet device connectivity, forms, and surveys. OptimizeRx Corporation is headquartered in Rochester, Michigan. .

Frequently asked questions

• What percentage of OptimizeRx Corporation is owned by insiders or institutions?

  Currently 13.952% of OptimizeRx Corporation shares are held by insiders and 64.534% by institutions.

• How many people work for OptimizeRx Corporation?

  Latest data suggests 71 work at OptimizeRx Corporation.

• When does the fiscal year end for OptimizeRx Corporation?

  OptimizeRx Corporation's fiscal year ends in December.

• Where is OptimizeRx Corporation based?

  OptimizeRx Corporation's address is: 400 Water Street, Rochester, MI, United States, 48307

• What is OptimizeRx Corporation's ISIN number?

  OptimizeRx Corporation's international securities identification number is: US68401U2042

• What is OptimizeRx Corporation's CUSIP number?

  OptimizeRx Corporation's Committee on Uniform Securities Identification Procedures number is: 68401U105